These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20012656)

  • 1. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Janik P; Kwiecinski H; Sokolowska B; Niebroj-Dobosz I
    J Neural Transm (Vienna); 2010 Mar; 117(3):343-7. PubMed ID: 20012656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination.
    Carilho R; de Carvalho M; Kuehl U; Pinto S; Pinto A; Kromminga A; Costa J
    Amyotroph Lateral Scler; 2011 Nov; 12(6):439-43. PubMed ID: 21722017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.
    Just N; Moreau C; Lassalle P; Gosset P; Perez T; Brunaud-Danel V; Wallaert B; Destée A; Defebvre L; Tonnel AB; Devos D
    Neuromuscul Disord; 2007 Feb; 17(2):169-73. PubMed ID: 17142042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
    Brettschneider J; Widl K; Ehrenreich H; Riepe M; Tumani H
    Neurosci Lett; 2006 Sep; 404(3):347-51. PubMed ID: 16815630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.
    Iłzecka J; Kocki T; Stelmasiak Z; Turski WA
    Acta Neurol Scand; 2003 Jun; 107(6):412-8. PubMed ID: 12757473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
    Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
    Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kasai T; Tokuda T; Ishigami N; Sasayama H; Foulds P; Mitchell DJ; Mann DM; Allsop D; Nakagawa M
    Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.
    Xenocostas A; Cheung WK; Farrell F; Zakszewski C; Kelley M; Lutynski A; Crump M; Lipton JH; Kiss TL; Lau CY; Messner HA
    Eur J Clin Pharmacol; 2005 May; 61(3):189-95. PubMed ID: 15776276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Liu J; Gao L; Zang D
    PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.
    Iłzecka J
    Acta Neurol Scand; 2003 Aug; 108(2):125-9. PubMed ID: 12859290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Cytokine; 2002 Dec; 20(5):239-43. PubMed ID: 12550109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.